ONVO READ THE FULL ONVO RESEARCH REPORT Organovo Holdings (NASDAQ:ONVO) is a biotechnology company that is both a developer of 3D tissue technology that has the potential to change the way treatments ...
Studies have demonstrated that lower levels of HSD17B13 expression are associated with poor HCC outcomes. The gene's downregulation in liver cancer tissues contrasts with its protective effects in ...
Hepatitis E Virus, or HEV, is a viral infection that generates inflammation of the liver. The disease is commonly transmitted through contact with contamin | Immunology ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.